Coccidioidomycosis Collaborative Research Centers
This grant supports collaborative research centers developing a vaccine for coccidioidomycosis (Valley fever) through basic research, new tools, and clinical studies in endemic U.S. regions.
Funder: National Institutes of Health
Due Dates: March 6, 2026 (Estimated application due date) | July 9, 2026 (Application submission deadline)
Funding Amounts: Up to $1,200,000 per award; estimated total program funding $4,800,000; expected 4 awards; project period and annual amounts may vary.
Summary: Supports collaborative, multi-disciplinary research centers to advance translational and clinical research for developing a Valley fever (coccidioidomycosis) vaccine.
Key Information: Clinical trials are not allowed; foreign organizations are not eligible to apply.
Description
This funding opportunity supports the establishment of Coccidioidomycosis Collaborative Research Centers (CCRCs) focused on advancing translational and clinical research to enable the development of a vaccine against Valley fever, a serious fungal infection endemic to several U.S. regions. The National Institute of Allergy and Infectious Diseases (NIAID) aims to foster highly collaborative and multi-disciplinary teams that address gaps in basic Coccidioides research, develop critical tools and resources, and drive progress toward a preventative vaccine. The initiative aligns with NIAID's strategic plan for Valley fever vaccine research and expects centers to leverage unique resources and patient populations from endemic regions.
